China Resources Boya Bio-pharmaceutical Group Co.,Ltd (SHE:300294)
China flag China · Delayed Price · Currency is CNY
13.25
-0.04 (-0.30%)
Nov 17, 2026, 3:04 PM CST

SHE:300294 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
749.61573.741,3001,9611,5321,584
Short-Term Investments
126.13108.14----
Trading Asset Securities
2,0372,5492,1993,3623,1942,700
Cash & Short-Term Investments
2,9123,2313,4995,3244,7264,284
Cash Growth
-6.54%-7.67%-34.28%12.66%10.31%468.21%
Accounts Receivable
749.85919.69509.38275.92567.02588.08
Other Receivables
167.3149.1739.81264.4100.6267.9
Receivables
917.16968.86549.19540.32667.64655.98
Inventory
1,114996.2995.43556.94666.96676.84
Other Current Assets
93.6437.8914.756.4313.2529.4
Total Current Assets
5,0375,2345,0586,4286,0735,646
Property, Plant & Equipment
1,5781,6511,170676.62722.81771.33
Long-Term Investments
143.1356.41407.51100.39117.09144.96
Goodwill
617.53617.5372872.61663.84663.84
Other Intangible Assets
415.42495.56773.28269.31312.17169.47
Long-Term Deferred Tax Assets
123.0183.2373.5447.3444.9927.44
Long-Term Deferred Charges
154.88145.29145.988.1582.64161.62
Other Long-Term Assets
181.9143.8444.38146.8316.2437.2
Total Assets
8,2518,6268,4017,8298,0337,622

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
245.69507.51357.62126.35303.46277.53
Accrued Expenses
91.04421.14323.81274.14290.9261.19
Current Portion of Long-Term Debt
---0.0322.180.08
Current Portion of Leases
6.385.795.330.872.812.06
Current Income Taxes Payable
10.12.0812.448.5827.0941.45
Current Unearned Revenue
10.118.124.0812.2120.5812.97
Other Current Liabilities
298.9589.1647.0934.2638.3335.66
Total Current Liabilities
662.271,034750.38456.45705.34630.94
Long-Term Debt
58.2947.07-22.15-22.15
Long-Term Leases
9.4912.737.171.410.3711.3
Long-Term Unearned Revenue
15.7525.3919.5123.5227.0930.98
Long-Term Deferred Tax Liabilities
55.2968136.324.565.565.94
Total Liabilities
801.11,187913.38508.07748.35701.3

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
504.25504.25504.25504.25504.25511.63
Additional Paid-In Capital
4,0634,0634,0634,0634,0654,258
Retained Earnings
2,8992,8742,9182,7532,6162,259
Treasury Stock
------199.96
Comprehensive Income & Other
-16.69-3.522.36---
Total Common Equity
7,4507,4387,4877,3207,1866,829
Minority Interest
-0.21.550.611.0799.1991.4
Shareholders' Equity
7,4507,4397,4887,3217,2856,920
Total Liabilities & Equity
8,2518,6268,4017,8298,0337,622

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
74.1665.5912.5124.4535.3635.58
Net Cash (Debt)
2,8383,1653,4865,2994,6904,248
Net Cash Growth
-8.69%-9.22%-34.21%12.99%10.41%903.09%
Net Cash Per Share
5.426.186.9410.499.339.74
Filing Date Shares Outstanding
504.25504.25504.25504.25504.25504.25
Total Common Shares Outstanding
504.25504.25504.25504.25504.25504.25
Working Capital
4,3754,2004,3085,9715,3685,015
Book Value Per Share
14.7714.7514.8514.5214.2513.54
Tangible Book Value
6,4176,3255,9866,9786,2105,996
Tangible Book Value Per Share
12.7312.5411.8713.8412.3111.89
Buildings
-655.73741.4527.95518.01536.62
Machinery
-715.37839.25625.83671.97665.73
Construction In Progress
-938.5732139.9469.3440.86